CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Mosaic ImmunoEngineering Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.33+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.41M
- P/E (TTM)
- –
- Dividend yield
- –
Mosaic ImmunoEngineering statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Mosaic ImmunoEngineering | Industry median |
|---|---|---|
| Market Cap | $2.41M | $197.05M |
| Enterprise Value | $2.41M | $106.56M |
Income (trailing twelve months)
| Measure | Mosaic ImmunoEngineering | Industry median |
|---|---|---|
| Operating Income | -$604.01K | -$21.44M |
| Pretax Income | -$687.35K | -$14.45M |
| Net Income | -$687.35K | -$22.46M |
| EBITDA | -$604.01K | -$16.91M |
| EPS (Diluted) | -$0.08 | -$0.83 |
Returns
| Measure | Mosaic ImmunoEngineering | Industry median |
|---|---|---|
| Return on Assets (ROA) | -2254.4% | -41.0% |
Balance sheet
| Measure | Mosaic ImmunoEngineering | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $26 | $62.42M |
| Net Cash (Debt) | $26 | $15.68M |
| Net Cash Per Share | $0.00 | $0.65 |
| Equity (Book Value) | -$7.83M | $48.79M |
| Book Value Per Share | -$1.08 | $1.36 |
| Tangible Book Value | -$7.83M | $23.06M |
| Working Capital | -$6.33M | $75.77M |
Financial position
| Measure | Mosaic ImmunoEngineering | Industry median |
|---|---|---|
| Current Ratio | 0.00 | 3.30 |
| Quick Ratio | 0.00 | 2.39 |
| Interest Coverage | -60.40 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Mosaic ImmunoEngineering | Industry median |
|---|---|---|
| Operating Cash Flow | -$53.56K | -$12.35M |
Efficiency
| Measure | Mosaic ImmunoEngineering | Industry median |
|---|---|---|
| Profits Per Employee | -$343.67K | -$732.08K |
| Employee Count | 2 | 73 |
Dividends and yields
| Measure | Mosaic ImmunoEngineering | Industry median |
|---|---|---|
| Earnings Yield | -28.5% | -21.2% |
Shares
| Measure | Mosaic ImmunoEngineering | Industry median |
|---|---|---|
| Shares Outstanding | 7,242,140 | 59,128,900 |
| Shares Change (YoY) | 0.00% | 11.1% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 7,242,140 | 48,744,500 |
| Shares Held by Insiders | 0.00% | 11.8% |
Taxes
| Measure | Mosaic ImmunoEngineering | Industry median |
|---|---|---|
| Income Tax | $0 | $91.50K |
Scores
| Measure | Mosaic ImmunoEngineering | Industry median |
|---|---|---|
| Altman Z-Score | -7143.15 | 0.10 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Mosaic ImmunoEngineering's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.